Ralph Augostini is a Cardiology physician affiliated with The Ohio State University Wexner Medical Center. OpenAlex indexes 143 publications with 2,628 citations (h-index 30); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
452 W 10th Ave
Columbus, OH 432101240
Telephone
614-293-7677Provider last certified this registry record 17 Apr 2026.
Clinical trials
- High-resolution MRI of Atrial Fibrillation Patients Prior to Focal Impulse and Rotor Modulation (FIRM) Ablation
Sponsor: Ohio State University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year202520 payments$10,825openpaymentsdata.cms.gov ↗
- ZOLL Respicardia, Inc.Program year20255 payments
- Medtronic, Inc.Program year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
68.2%Antiarrhythmic27.9%Amiodarone Hcl43%Dofetilide23%Mexiletine Hcl14%Propafenone Hcl Er8%Flecainide Acetate8%Quinidine Gluconate4%Part D<11 patientsBeta blocker23.2%Metoprolol Succinate52%Sotalol34%Metoprolol Tartrate9%Carvedilol5%Part D<11 patients+ 7 more classes in this area
Blood & clotting
30.2%Factor Xa inhibitor26.2%Eliquis79%Xarelto22%Part D≥74 patientsVitamin K antagonist3.1%Warfarin Sodium100%Part D≥14 patients+ 1 more class in this area
Metabolism & gastrointestinal
1.7%Potassium supplement1.7%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Timothy Pawlik, MD
The Ohio State University Wexner Medical Center
Colleen Cebulla, MD
The Ohio State University Wexner Medical Center
Michael Grever, MD
The Ohio State University Wexner Medical Center
Brad Rovin, MD
The Ohio State University Wexner Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”